LINC00965
gene geneOn this page
Summary
LINC00965 (long intergenic non-protein coding RNA 965, HGNC:28022) is a long non-coding RNA gene on chromosome 8p23.1.
At a glance
- GWAS associations: 1
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28022 |
| Approved symbol | LINC00965 |
| Name | long intergenic non-protein coding RNA 965 |
| Location | 8p23.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Entrez | 349196 |
| RNAcentral | URS000075C1DB — lncRNA, 2874 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1156619397 (8:7261992 G>A), RS1158083650 (8:7263783 A>G), RS1158540514 (8:7263226 C>A), RS1159044484 (8:7263685 A>T), RS1159837465 (8:7263508 A>G), RS1160993068 (8:7264016 C>G), RS1161083610 (8:7263450 G>A), RS1161254789 (8:7263002 C>T), RS1161271727 (8:7263574 G>A), RS1163163132 (8:7261697 C>T), RS1164145479 (8:7263579 G>A,T), RS1166770513 (8:7263504 T>C), RS1168408556 (8:7263405 C>G), RS1168938059 (8:7262799 C>G), RS1169411112 (8:7263576 GA>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002927_15 | Mercury levels | 4.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression, affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| butyraldehyde | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.